China Shows Sharp Decline In Registration Approval Of Generic Drugs Last Year
This article was originally published in PharmAsia News
Executive Summary
Last year, China's State FDA approved the registration applications of 651 generic drugs, constituting 73 percent of the year's approved 1,000 applications and dropping by 11 times from 2005, according to a recent SFDA conference on drug registration